0
0
VIJAYAWADA, INDIA — In a major policy shift aimed at addressing one of the most fragmented and expensive sectors of public health, the Andhra Pradesh government has announced the formulation of a comprehensive state-level rare disease policy. The initiative will establish a dedicated state registry, introduce mandatory newborn screening, and create a specialized referral network across major teaching hospitals.
Announced ahead of a pivotal stakeholder consultation scheduled for June 24, 2026, at Dr. NTR University of Health Sciences in Vijayawada, the draft policy aims to integrate local healthcare infrastructure with India’s National Policy for Rare Diseases, 2021. By upgrading existing teaching hospitals into referral hubs, the state intends to provide free diagnostic support, genetic counseling, and structured financial assistance to thousands of families currently navigating these complex conditions in isolation.
The Hidden Weight of “Uncommon” Conditions
While an individual rare disease may affect only a small fraction of the population, their collective impact is a significant public health challenge. According to data from the Indian Council of Medical Research (ICMR), there are thousands of recognized rare disorders worldwide, the vast majority of which are genetic. In India, a peer-reviewed national strategy review indexed in PubMed highlights that while these conditions are individually rare, they collectively contribute substantially to early childhood illness and mortality.
For families, the journey to a correct diagnosis is frequently described as an “odyssey.” On average, patients experience years of diagnostic delays, multiple misdiagnoses, and catastrophic out-of-pocket healthcare expenses.
“Rare diseases are not rare in the aggregate,” notes Dr. Sunita Iyer, a public health specialist who has advocated for regional screening programs. “Because 80% of these conditions are genetic in origin, they frequently strike children. Without a coordinated public system, the average family spends years moving between local clinics before even hearing the correct name of their child’s condition.”
Beyond a List of Names: Why a State Registry Matters
A central pillar of the new Andhra Pradesh policy is the creation of a state-specific rare disease registry. Public health experts emphasize that a registry is not merely an administrative roster; it is a vital epidemiological tool. By systematically tracking who is affected, specific genetic variants, geographic clusters, and treatment outcomes, the state can replace guesswork with data-driven planning.
This approach builds upon national infrastructure. The ICMR launched the National Registry for Rare and Other Inherited Disorders (NRROID) in November 2019, which expanded to include 19 data-collection centers nationwide.
A recent implementation analysis of the national registry published in early 2025 demonstrated the power of this data, revealing that coordinated systems had successfully enrolled 15,369 patients across 231 distinct rare diseases. For Andhra Pradesh, a localized registry means the government can accurately project the exact demand for orphan drugs (medicines used to treat rare medical conditions), genetic testing kits, and specialized counseling services.
Decentralizing Expert Care
Currently, patients in Andhra Pradesh suspected of having complex genetic disorders often must travel long distances to major metropolitan hubs in other states for tertiary evaluations.
To resolve this geographic disparity, the draft policy targets the state’s existing medical infrastructure. The government is evaluating teaching hospitals in four key cities to serve as the backbone of the new care network:
-
Visakhapatnam
-
Tirupati
-
Vijayawada
-
Kakinada
One of these premier facilities will be upgraded to function as an official Centre of Excellence (CoE).
Advocacy groups, including the Indian Organisation for Rare Diseases (IORD), have long maintained that a regional CoE model is essential for equitable care. A localized center ensures that clinical expertise, advanced laboratory diagnostics, and multi-disciplinary medical boards are accessible closer to home, preventing vulnerable patients from being lost in the referral chain.
Alignment with National Funding
The blueprint aligns with India’s evolving federal framework. Under the National Policy for Rare Diseases, 2021, the Ministry of Health and Family Welfare initially structured conditions into three categories based on treatment cost and predictability. The central framework originally provided up to ₹20 lakh for one-time curative treatments.
Subsequent updates, confirmed in parliamentary replies, expanded this financial support up to ₹50 lakh per patient for treatments administered at designated Centres of Excellence, while encouraging state governments to build regional support networks for long-term management. By establishing a formalized framework, Andhra Pradesh positions its citizens to better access these expanded federal funds and specialized therapeutics.
Practical Implications for Families and Physicians
For health-conscious consumers and affected families, the policy promises a clearer, institutional pathway. Instead of navigating a complex web of private clinics, families will have access to standardized newborn screening and early genetic counseling—interventions that are critical for conditions where delayed treatment causes irreversible neurological or physical damage.
For frontline clinicians and pediatricians, the policy will introduce formal reporting protocols and training programs. This educational push aims to elevate clinical suspicion of rare conditions during routine outpatient visits, ensuring early identification and seamless referral to the state’s upcoming tertiary hubs.
Policy Challenges and Limitations
Despite the optimism surrounding the draft, public health authorities urge realistic expectations regarding implementation. Medical registries inherently face an initial undercounting bias; because many individuals in rural or underserved districts remain entirely undiagnosed, early registry data will likely represent only a fraction of the actual disease burden.
Furthermore, a registry and a referral network are only as effective as the funding behind them. While the central government has increased individual patient caps to ₹50 lakh at Centres of Excellence, the global cost of orphan drugs remains prohibitively high, and many conditions still lack any approved therapeutic intervention. The ultimate success of Andhra Pradesh’s initiative will depend on sustained financial allocations, the rapid procurement of advanced diagnostic equipment, and the consistent training of specialized laboratory personnel.
As the stakeholder consultation concludes at Dr. NTR University of Health Sciences, the transition from paper policy to clinical reality will serve as a critical benchmark for how Indian states manage rare diseases in the modern era.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
- https://medicaldialogues.in/state-news/andhra-pradesh/andhra-pradesh-to-set-up-rare-diseases-registry-centre-of-excellence-under-new-policy-173403
